ACC 2026 Statements: Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of ASCVD

Clinical Guideline InSights · Jul 16, 2026 · 17m

The 2026 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events Scientific Statement and the 2026 Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease Scientific Statement

Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events/Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease

American College of Cardiology

June 30, 2026

Guideline Summary: https://www.guidelinecentral.com/guideline/5230408/ / https://www.guidelinecentral.com/guideline/5230407/

Full-Text…